Evidence map›Paper›PMID 26509579›Full record

ArticlePloS one2015

Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing.

Mark Klinger, Francois Pepin, Jen Wilkins, Thomas Asbury, Tobias Wittkop, Jianbiao Zheng, Martin Moorhead, Malek Faham

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 1 synthesis or guideline pooled it, 147 citations in OpenAlex.

  1. Resolving SARS-CoV-2 CD4Cell reports. Medicine · 2022
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. T Cell Thoughts.Immunological reviews · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mark KlingerAdaptive Biotechnologies, South San Francisco, CA 94080, United States of America.
Francois PepinAdaptive Biotechnologies, South San Francisco, CA 94080, United States of America.
Jen WilkinsAdaptive Biotechnologies, South San Francisco, CA 94080, United States of America.
Thomas AsburyAdaptive Biotechnologies, South San Francisco, CA 94080, United States of America.
Tobias WittkopAdaptive Biotechnologies, South San Francisco, CA 94080, United States of America.
Jianbiao ZhengAdaptive Biotechnologies, South San Francisco, CA 94080, United States of America.
Martin MoorheadAdaptive Biotechnologies, South San Francisco, CA 94080, United States of America.
Malek FahamAdaptive Biotechnologies, South San Francisco, CA 94080, United States of America.
Adaptive Biotechnologies (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monitoring antigen-specific T cells is critical for the study of immune responses and development of biomarkers and immunotherapeutics. We developed a novel multiplex assay that combines conventional immune monitoring techniques and immune receptor repertoire sequencing to enable identification of T cells specific to large numbers of antigens simultaneously. We multiplexed 30 different antigens and identified 427 antigen-specific clonotypes from 5 individuals with frequencies as low as 1 per million T cells. The clonotypes identified were validated several ways including repeatability, concordance with published clonotypes, and high correlation with ELISPOT. Applying this technology we have shown that the vast majority of shared antigen-specific clonotypes identified in different individuals display the same specificity. We also showed that shared antigen-specific clonotypes are simpler sequences and are present at higher frequencies compared to non-shared clonotypes specific to the same antigen. In conclusion this technology enables sensitive and quantitative monitoring of T cells specific for hundreds or thousands of antigens simultaneously allowing the study of T cell responses with an unprecedented resolution and scale.

Indexed as

Enzyme-Linked Immunospot AssayHigh-Throughput Nucleotide SequencingClonal EvolutionEpitopes, T-LymphocyteHumansReceptors, Antigen, T-CellReceptors, ImmunologicReproducibility of ResultsT-Cell Antigen Receptor SpecificityEpitopes, T-LymphocyteReceptors, Antigen, T-CellReceptors, Immunologic

Identifiers

PMID26509579
PMCPMC4624875
OpenAlexW1822028895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.